GVR Report cover Analgesics Market Size, Share & Trends Report

Analgesics Market Size, Share & Trends Analysis Report By Drug Class (Opioid, Non-opioid, Compound medication), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2022 To 2030

  • Report ID: GVR453516
  • Number of Pages: 0
  • Format: Electronic (PDF)

Pain relieving analgesics are available over the counter, but strong variants are available only with prescription. This is due to the side-effects associated with strong analgesics such as addiction, dependence, and withdrawal symptoms. The space has a substantial presence of non-opioid such as NSAIDs for treating mild to moderate pain, opioid analgesics treating moderate to severe conditions and compound analgesics containing combination of non-opioids along with opioid such as low strength codeine.

Global rise in prevalence of chronic diseases such as cardiovascular disorder and cancer, increasing ageing population is fueling the demand in the market. In 2018, according to the CDC, over 27.5% of U.S. adult population is suffering from multiple chronic conditions. In addition, upsurge in healthcare expenditure is accelerating this segment of pharma industry.

The market has been mainly segmented as:

  • Oral

  • Parentals

  • Transdermal

  • Others

The advancement in designing novel formulations to enhance utility or improved safety of existing medications is driving the market growth. For example, Sun Pharma’s Volini Maxx is available is pain reliving spray. Similarly, morphine, tramadol and oxycodone are available as novel extended release, diclofenac, lidocaine and fentanyl patches as local route of administration, and oral lozenges of fentanyl.

The rising cases of unsuccessful pain management with opioid analgesics is demanding higher doses of drugs. However, this is leading to drug tolerance and eventually increasing risk of addiction. Strategically commercializing opioid-tolerant drugs with reduced side effects is offering lucrative opportunity for market growth. In addition, this drug class is associated with non-medical and illegal use, encouraging physicians to prescribe non-opioid analgesics. Thus, an opportunity for key players to develop such novel segment.

Furthermore, key players in the analgesics market are undertaking initiatives focusing on innovations, developing novel approaches, mergers, and regional expansions. For instance, in May 2020, Assertio Therapeutics, Inc. announced merger of Zyla Life Sciences, an initiative to commercially grow pain management products of Zyla. Moreover, in September 2020 launch of GlaxoSmithKline’s Advil Dual Action formulation, consisting of drug combination such as acetaminophen and ibuprofen is expected to drive the market growth.

                                    Analgesics Market Segmentation 



Drug Type

Opioid, Non-opioid, Compound medication

Route of Administration

Oral, Parenteral, Transdermal, Others


Musculoskeletal, Surgical and Trauma, Cancer, Neuropathic, Migraine, Obstetrical, Fibromyalgia, Pain due to Burns, Dental/Facial, Pediatric

Distribution Channel

Hospital pharmacies, Retail pharmacies, Online pharmacies


North America; Europe; Asia Pacific; Latin America; Middle East and Africa (MEA)


Major companies operating in the analgesics market include Bayer AG, Pfizer Inc., F. Hoffmann-La Roche Ltd., Endo Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Assertio Therapeutics, Inc. Sanofi, Janssen Pharmaceuticals, Inc., Novartis AG, and GlaxoSmithKline PLC.

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon